Elrig

MARCH 25, 2025

Prof Rory Johnson is an Associate Professor at University College Dublin, where his research focusses on uncovering the roles of long noncoding RNAs (lncRNAs) in human health and disease using an interdisciplinary combination of bioinformatic and experimental methods.

RNA 59

RNA Bioinformatics Science Pharmacokinetics 59

Drug Target Review

MARCH 19, 2024

Our polygenic score will enable the application of these treatments to people that specifically need it through precision medicine by identifying the individual at high genetic risk of low circulating levels of the vitamin. The answer is no because there are both genetic and dietary (environmental) causes for low vitamin A.

Laboratories 105

Laboratories Bioinformatics International Research Laboratories 105

The Open Targets Blog

OCTOBER 31, 2023

The CCDI Molecular Targets Platform (MTP) is a collaborative effort between the Children’s Hospital of Philadelphia and the Frederick National Laboratory with input from the NCI and the U.S. Clinicians decide on an optimal treatment regimen based on the patient’s cancer subtype. Food and Drug Administration (FDA).

Bioinformatics 67

Bioinformatics Engineering Clinical Trials Therapies 67

The Open Targets Blog

OCTOBER 24, 2023

Amir Feizi is the Director of Bioinformatics at OMass Therapeutics, a spinout from Professor Dame Carol Robinson’s Laboratory at the University of Oxford. OMass Therapeutics is using a new technology platform to develop treatments for rare immunological and genetic diseases with high unmet patient needs.

Bioinformatics 62

Bioinformatics Packaging Pharmaceutical Companies Pharma Companies 62

Drug Target Review

SEPTEMBER 26, 2024

This enables us to explore novel drug candidates that could be more effective or have fewer side effects than existing treatments and drugs. Mutlu has a robust academic background that includes a bachelor’s degree in physics, a master’s degree in bioengineering, and a PhD in bioinformatics from the University of Cambridge.

Drugs 64

Drugs Production Research Small Molecule 64

Drug Target Review

JULY 24, 2023

The study suggests that this regulatory system could be a potential target for future malaria treatments, offering hope for combatting this deadly disease that affects millions worldwide. With this newfound knowledge, there is renewed hope in the pursuit of effective malaria treatments alleviating the suffering of millions affected.

RNA 98

RNA Regulations Bioinformatics Laboratories 98

Drug Target Review

JUNE 13, 2024

Study co-senior investigator Dr Aristotelis Tsirigos is a professor in the Departments of Pathology and Medicine at NYU Grossman School of Medicine and Perlmutter Cancer Center, where he also is co-director of precision medicine and director of its Applied Bioinformatics Laboratories.

Bioinformatics 45

Bioinformatics Disease Laboratories Hospitals 45